These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 9849416
1. Immunohistochemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer. Kawasaki M, Nakanishi Y, Kuwano K, Takayama K, Kiyohara C, Hara N. Eur J Cancer; 1998 Aug; 34(9):1352-7. PubMed ID: 9849416 [Abstract] [Full Text] [Related]
2. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer. Kawasaki M, Nakanishi Y, Kuwano K, Yatsunami J, Takayama K, Hara N. Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799 [Abstract] [Full Text] [Related]
3. Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers. Harada T, Ogura S, Yamazaki K, Kinoshita I, Itoh T, Isobe H, Yamashiro K, Dosaka-Akita H, Nishimura M. Cancer Sci; 2003 Apr; 94(4):394-9. PubMed ID: 12824911 [Abstract] [Full Text] [Related]
10. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Yoh K, Ishii G, Yokose T, Minegishi Y, Tsuta K, Goto K, Nishiwaki Y, Kodama T, Suga M, Ochiai A. Clin Cancer Res; 2004 Mar 01; 10(5):1691-7. PubMed ID: 15014021 [Abstract] [Full Text] [Related]
11. Immunohistochemical study of p53 in non-small cell lung cancer before and after preoperative chemotherapy. Korobowicz E, Zdunek M. Pol J Pathol; 2000 Mar 01; 51(2):71-6. PubMed ID: 10974929 [Abstract] [Full Text] [Related]
12. Immunohistochemical expression of MRP2 and clinical resistance to platinum-based chemotherapy in small cell lung cancer. Ushijima R, Takayama K, Izumi M, Harada T, Horiuchi Y, Uchino J, Hara N, Nakanishi Y. Anticancer Res; 2007 Mar 01; 27(6C):4351-8. PubMed ID: 18214043 [Abstract] [Full Text] [Related]
15. p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. Linn SC, Honkoop AH, Hoekman K, van der Valk P, Pinedo HM, Giaccone G. Br J Cancer; 1996 Jul 01; 74(1):63-8. PubMed ID: 8679460 [Abstract] [Full Text] [Related]
20. Multidrug resistance-associated protein and mutant p53 protein expression in non-small cell lung cancer. Oshika Y, Nakamura M, Tokunaga T, Fukushima Y, Abe Y, Ozeki Y, Yamazaki H, Tamaoki N, Ueyama Y. Mod Pathol; 1998 Nov 01; 11(11):1059-63. PubMed ID: 9831202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]